CoChat

Growth Hormone Decreases Visceral Fat and Improves Cardiovascular Risk Markers in Women with Hypopituitarism: A Randomized, Placebo-Controlled Study

Open access

The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.

Abstract

Context Data regarding gender-specific efficacy of GH on critical endpoints are lacking. There are no randomized, placebo-controlled studies of physiological GH therapy solely in women. Objective Our objective was to determine the effects of physiological GH replacement on cardiovascular risk markers and body composition in women with GH deficiency (GHD). Design This was a 6-month, randomized, placebo-controlled, double-blind study. Setting The study was conducted at the General Clinical Research Center. Study participants 43 women with GHD due to hypopituitarism were included in the study. Intervention Study participants were randomized to receive GH (goal mid-normal serum IGF-1) or placebo. Main outcome measures Cardiovascular risk markers, including high-sensitivity C-reactive protein, tissue plasminogen activator, and body composition, including visceral adipose tissue by cross-sectional computed tomography, were measured. Results Mean daily GH dose was 0.67 mg. The mean IGF-1 sd score increased from -2.5 +/- 0.3 to -1.4 +/- 0.9 (GH) (P Conclusions Low-dose GH replacement in women with GHD decreased total and visceral adipose tissue and improved cardiovascular markers, with a relatively modest increase in IGF-1 levels and without worsening insulin resistance.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2007-2371

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Wuster, 1991, Klin Wochenschr, 769

Cited by

See all 99

Metadata

Authors
Beauregard, C., Utz, A. L., Schaub, A. E., Nachtigall, L., Biller, B. M. K., Miller, K. K., & Klibanski, A.
Affiliations
Harvard University (US)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2008-06-01
Volume
93
Issue
6
Pages
2063-2071
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1968009970
Cited by
99
References
67
Citations by year
2025: 3 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 5 · 2019: 1 · 2018: 8 · 2017: 9 · 2016: 4 · 2015: 3 · 2014: 11 · 2013: 8 · 2012: 9
FWCI
7.50
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK040561)
  • National Center for Research Resources (M01RR001066, M01-RR01066)
  • NIH Clinical Center
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
growth hormone replacement therapy, growth hormone deficiency, hypopituitarism, women, visceral adipose tissue, body composition, cardiovascular risk markers, C-reactive protein, tissue plasminogen activator, insulin-like growth factor I, insulin resistance, cholesterol, HDL cholesterol, inflammation, fat loss
MeSH terms
Adult, Aged, Body Composition, Cardiovascular Diseases, Double-Blind Method, Female, Glucose, Humans, Hypopituitarism, Insulin-Like Growth Factor I, Lipids, Lipoproteins, Middle Aged, Placebos, Risk Factors, Growth Hormone, Biomarkers, Human Growth Hormone, Intra-Abdominal Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.